Oda Robert, Shiramizu Bruce, Agsalda-Garcia Melissa, Kettlewell Joanna, Wojna Valerie
Department of Molecular Biosciences & Bioengineering, College of Tropical Agriculture and Human Resources, University of Hawaii at Manoa, Honolulu, Hawaii.
Department of Tropical Medicine, Medical Microbiology & Pharmacology, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii.
P R Health Sci J. 2018 Sep;37(3):155-159.
HIV-associated cognitive impairment (HACI) continues to persist for HIV-seropositive individuals who are on antiretroviral therapy (ART). HACI develops in part when HIV-infected monocytes (MOs) transmigrate through the blood-brain barrier (BBB) and secrete pro-inflammatory cytokines and chemokines, which leads to neuronal damage. In vitro BBB models are important tools that can elucidate mechanisms of MO transmigration. Previously described in vitro BBB models relied on pathology specimens, resulting in potentially variable and inconsistent results. This project reports on a reliable and consistent alternative in vitro BBB model that has the potential to be used in clinical research intervention studies analyzing the effects of ART on the BBB and on MO transmigration.
A bilayer BBB model was established with commercially available astrocytes and endothelial cells on a 3μm PET membrane insert to allow the contact of astrocytic foot processes with endothelial cells. Inserts were cultured in growth medium for 7 days before exposure to HIV- or HIV+ peripheral blood mononuclear cells (PBMCs). PBMCs were allowed to transmigrate across the BBB for 24 hours.
Confluency and integrity measurements by trans-endothelial electrical resistance (TEER) (136.7 ± 18.3Ω/cm2) and permeability (5.64 ± 2.20%) verified the integrity of the in vitro BBB model. Transmigrated MOs and non-MOs were collected and counted (6.0x104 MOs; 1.1x105 non-MOs). Markers indicative of glial fibrillary acidic protein (GFAP), von Willebrand factor (vWF), and p-glycoprotein (Pgp) were revealed in immunofluorescence staining (IF), indicating BBB phenotype and functionality.
Potential applications for this model include assessing the HIV DNA copy numbers of transmigrated cells (pre- and post-targeted ART) and understanding the role of oxidative stress related to HIV DNA and HACI.
对于接受抗逆转录病毒疗法(ART)的HIV血清反应阳性个体,HIV相关认知障碍(HACI)仍然存在。当HIV感染的单核细胞(MOs)穿过血脑屏障(BBB)并分泌促炎细胞因子和趋化因子时,部分会引发HACI,进而导致神经元损伤。体外血脑屏障模型是能够阐明MO迁移机制的重要工具。先前描述的体外血脑屏障模型依赖于病理标本,结果可能存在变化且不一致。本项目报告了一种可靠且一致的体外血脑屏障替代模型,该模型有潜力用于临床研究干预试验,以分析ART对血脑屏障和MO迁移的影响。
使用市售的星形胶质细胞和内皮细胞在3μm聚对苯二甲酸乙二酯(PET)膜插入物上建立双层血脑屏障模型,使星形胶质细胞的足突与内皮细胞接触。在暴露于HIV或HIV阳性外周血单核细胞(PBMCs)之前,将插入物在生长培养基中培养7天。使PBMCs穿过血脑屏障迁移24小时。
通过跨内皮电阻(TEER)(136.7±18.3Ω/cm2)和通透性(5.64±2.20%)进行的融合度和完整性测量验证了体外血脑屏障模型的完整性。收集并计数迁移的MOs和非MOs(6.0×104个MOs;1.1×105个非MOs)。免疫荧光染色(IF)显示了指示胶质纤维酸性蛋白(GFAP)、血管性血友病因子(vWF)和P-糖蛋白(Pgp)的标志物,表明血脑屏障的表型和功能。
该模型的潜在应用包括评估迁移细胞(靶向ART前后)的HIV DNA拷贝数,以及了解与HIV DNA和HACI相关的氧化应激作用。